Peptide ProvidersDirect
iThriveMD logo
Unclaimed12 services cataloged

iThriveMD

Encinitas, CA · Telehealth available

Visit provider website ↗

Provider overview

About iThriveMD

iThriveMD identifies Samir Damani, MD, as founder and publishes nine physical California clinic addresses plus a Scottsdale telehealth option. Its peptide page says peptide services are currently available at the Encinitas and Mission Valley clinics. The named compounds and programs below are provider-advertised offerings; the listing does not establish regulatory status, availability at every location, safety, effectiveness, or individual eligibility.

At a glance

Market role
Direct patient-care provider
Care model
Telehealth and In person
Coverage
2 listed jurisdictions
Pharmacy pathway
Not publicly established
Medical weight managementHormone healthLongevity medicineMetabolic healthLaboratory testing

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Services advertised on the provider’s public website, organized by area of care.

12 cataloged
01

Provider-advertised recovery peptides

Service 01

BPC-157, TB-500, and Wolverine blend

iThriveMD names these compounds and blend in recovery-oriented protocols; the directory does not adopt the provider's repair or outcome claims.

View provider source
02

Provider-advertised skin and recovery peptides

Service 01

GHK-Cu and Glow blend

The clinic lists GHK-Cu and a blend containing GHK-Cu, BPC-157, and TB-500; inclusion does not establish approval, safety, or effectiveness.

View provider source
03

Provider-advertised cognitive peptides

Service 01

Semax and Selank

These nasal peptide offerings appear in the clinic's cognitive-optimization catalog and remain subject to medical evaluation.

View provider source
04

Sexual health

Service 01

PT-141

PT-141 is listed as a clinician-prescribed sexual-wellness offering in the current peptide catalog.

View provider source
05

Provider-advertised longevity peptides

Service 01

Epithalon and MOTS-C

The clinic names these compounds in its performance and longevity pathway; the listing makes no regulatory or clinical endorsement.

View provider source
06

Provider-advertised immune-health peptides

Service 01

Thymosin Alpha-1

Thymosin Alpha-1 appears in the provider's peptide catalog as an immune-health pathway subject to provider assessment.

View provider source
07

Medical weight management

Service 01

Compounded semaglutide program

The clinic advertises clinician-reviewed compounded semaglutide with diagnostic review and ongoing monitoring.

View provider source
Service 02

Compounded tirzepatide program

The clinic advertises a compounded tirzepatide pathway with clinical intake and follow-up; patient eligibility is not implied.

View provider source
08

Hormone health

Service 01

Testosterone replacement and enclomiphene care

Laboratory-guided testosterone and enclomiphene pathways are listed for provider-diagnosed men's hormone concerns.

View provider source
Service 02

Female bioidentical hormone care

The clinic advertises individualized perimenopause and menopause hormone evaluation and treatment planning.

View provider source
09

Longevity and cellular wellness

Service 01

NAD+ injections and wafers

NAD+ injections and wafers are included in the current longevity catalog; the directory does not repeat the provider's outcome claims.

View provider source
10

Testing and ongoing care

Service 01

Comprehensive longevity laboratory panel

The clinic publishes a broad biomarker panel with in-clinic or virtual provider review and ongoing tracking.

View provider source
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.